Atorvastatin induces tissue transglutaminase in human endothelial cells

Biochemical and Biophysical Research Communications

Volumn 322, Issue 1, 2004, Pages 105-109

  Soehnlein, Oliver ^a   Eskafi, Saeed ^a   Schmeisser, Alexander ^b   Kloos, Heike ^a   Daniel, Werner G ^a   Garlichs, Christoph D ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Atherosclerosis; Coronary heart disease; Endothelial cells; Extracellular matrix; Tissue transglutaminase

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROPIDIUM IODIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BASEMENT MEMBRANE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; STAINING; UMBILICAL VEIN; UPREGULATION;

APOPTOSIS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTP-BINDING PROTEINS; HEPTANOIC ACIDS; HUMANS; PYRROLES; TRANSGLUTAMINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4143066871     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.087     Document Type: Article

References (30)

1. M. Toborek, and S. Kaiser Endothelial cell functions. Relationship to atherogenesis Basic Res. Cardiol. 94 1999 295 314
2. D.B. Cines, E.S. Pollak, C.A. Buck, J. Loscalzo, G.A. Zimmerman, R.P. McEver, J.S. Pober, T.M. Wick, B.A. Konkle, B.S. Schwartz, E.S. Barnathan, K.R. McCrae, B.A. Hug, A.M. Schmidt, and D.M. Stern Endothelial cells in physiology and in the pathophysiology of vascular disorders Blood 91 1998 3527 3561
3. C. Barsigian, A.M. Stern, and J. Martinez Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular curface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] diazolium derivates as cellular transglutaminase inactivators J. Biol. Chem. 266 1991 22501 22509
4. J.E. Folk, and P.W. Cole Transglutaminase: mechanistic features of the active sites as determined by kinetic and inhibitor studies Biochim. Biophys. Acta. 122 1966 244 264
5. D.C. Sane, T.L. Moser, C.J. Parker, D. Seiffert, and D.J. Loskutoff Vitronectin is a substrate for transglutaminases Biochem. Biophys. Res. Commun. 157 1988 115 120
6. D. Aeschlimann, and M. Paulsson Cross-linking of laminin-nidogen complexes by tissue transglutaminase: a novel mechanism for basement membrane stabilization J. Biol Chem. 266 1991 15308 15317
7. R.A. Jones, B. Nicholas, S. Mian, P.J. Davies, and M. Griffin Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin J. Cell Sci. 110 1997 2461 2472
8. J.M. Bowness, A.H. Tarr, and T. Wong Increased transglutaminase activity during skin wound healing in rats Biochim. Biophys. Acta 967 1988 234 240
9. Z.A. Haroon, J.M. Hettasch, T.S. Lai, M.W. Dewhirst, and C.A. Greenberg Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis FASEB J. 13 1999 1787 1795
10. D. Aeschlimann, D. Moser, and M. Paulsson Tissue transglutaminase and factor XIII in cartilage and bone remodelling Semin. Thromb. Hemost. 22 1996 437 443
11. C.S. Greenberg, P.J. Birckbichler, and R.H. Rice Transglutminases: multifunctional cross-linking enzymes that stabilize tissues FASEB J. 5 1991 3071 3077
12. D. Aeschlimann, and M. Paulsson Transglutaminases: protein cross-linking enzymes in tissues and body fluids Thromb. Haemost. 71 1994 402 415
13. Y. Sumi, N. Inoue, H. Azumi, T. Seno, M. Okuda, K. Hirata, S. Kawashima, Y. Hayashi, H. Itoh, and M. Yokoyama Expression of tissue transglutaminase and elafin in human coronary artery: implication for plaque instability Atherosclerosis 160 2002 31 39
14. West of Scotland Coronary Prevention Study Group, Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS), Circulation 97 (1998) 1440-1445
15. Scandinavian Simvastatin Survival Study Group, Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S), Lancet 345 (1995) 1274-1275
16. R. Collins, R. Peto, and J. Armitage The MRC/BHF Heart Protection Study: preliminary results Int. J. Clin. Pract. 56 2002 53 56
17. J.K. Liao Beyond lipid lowering: the role of statins in vascular protection Int. J. Cardiol. 86 2002 5 18
18. E.A. Jaffe, R.L. Nachman, and C.G. Becker Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria J. Clin. Invest. 52 1973 2745 2756
19. V. Gentile, V. Thomazy, M. Piacentini, L. Fesus, and P.J. Davies Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion J. Cell Biol. 119 1992 463 474
20. G.C. Auld, H. Ritchie, L.A. Robbie, and N.A. Booth Thrombin upregulates tissue transglutaminase in endothelial cells: a potential role for tissue transglutaminase in stability of atherosclerotic plaque Arterioscler. Thromb. Vasc. Biol. 21 2001 1689 1694
21. M. Lesort, K. Attanavanich, J. Zhang, and G.V. Johnson Distinct nuclear localization and activity of tissue transglutaminase J. Biol. Chem. 273 1998 11991 11994
22. E. Verderio, B. Nicholas, S. Gross, and M. Griffin Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death Exp. Cell Res. 239 1998 119 138
23. H.F. Upchurch, E. Conway, M.K. Patterson, and M.D. Maxwell Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme J. Cell. Physiol. 149 1991 375 382
24. S.S. Akimov, D. Krylov, L.F. Fleischman, and A.M. Belkin Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin J. Cell Biol. 148 2000 825 838
25. C.A. Gaudry, E. Verderio, R.A. Jones, C. Smith, and M. Griffin Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin Exp. Cell. Res. 252 1999 104 113
26. S. Kaneta, K. Satoh, S. Kano, M. Kanda, and K. Ichihara All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells Atherosclerosis 170 2003 237 243
27. C.J. Newton, G. Ran, Y.X. Xie, D. Bilko, C.H. Burgoyne, I. Adams, A. Abidia, P.T. McCollum, and S.L. Atkin Statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasone J. Endocrinol. 174 2002 7 16
28. F. Autuori, M.G. Farrace, S. Oliverio, L. Piredda, and M. Piacentini "Tissue" transglutaminase and apoptosis Adv. Biochem. Eng. Biotechnol. 62 1998 129 136
29. S.Y. Kim, E.J. Jeong, and P.M. Steinert IFN-gamma induces transglutaminase 2 expression in rat small intestinal cells J. Interferon Cytokine Res. 22 2002 677 682
30. G.S. Kuncio, M. Tsyganskaya, J. Zhu, S.L. Liu, L. Nagy, V. Thomazy, P.J. Davies, and M.A. Zern TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells Am. J. Physiol. 274 1998 G240 G245